Norifumi Morikawa

1.8k total citations
101 papers, 1.4k citations indexed

About

Norifumi Morikawa is a scholar working on Pharmacology, Epidemiology and Molecular Medicine. According to data from OpenAlex, Norifumi Morikawa has authored 101 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Pharmacology, 37 papers in Epidemiology and 33 papers in Molecular Medicine. Recurrent topics in Norifumi Morikawa's work include Antibiotics Pharmacokinetics and Efficacy (67 papers), Antibiotic Resistance in Bacteria (33 papers) and Pneumonia and Respiratory Infections (26 papers). Norifumi Morikawa is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (67 papers), Antibiotic Resistance in Bacteria (33 papers) and Pneumonia and Respiratory Infections (26 papers). Norifumi Morikawa collaborates with scholars based in Japan, United States and New Zealand. Norifumi Morikawa's co-authors include Kazuro Ikawa, Kazuaki Matsumoto, Yasuo Takeda, Kayo Ikeda, Akari Shigemi, Yuta Yokoyama, Erika Watanabe, Hiroki Ohge, Yoshihiro Shimodozono and Taijiro Sueda and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Antimicrobial Agents and Chemotherapy and Analytical and Bioanalytical Chemistry.

In The Last Decade

Norifumi Morikawa

99 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Norifumi Morikawa Japan 19 892 535 486 375 160 101 1.4k
Kazuro Ikawa Japan 23 1.2k 1.4× 735 1.4× 565 1.2× 526 1.4× 206 1.3× 127 1.9k
Arantxa Isla Spain 24 951 1.1× 451 0.8× 219 0.5× 393 1.0× 129 0.8× 59 1.6k
J. Blaser Switzerland 21 995 1.1× 544 1.0× 363 0.7× 654 1.7× 271 1.7× 51 1.6k
Sutep Jaruratanasirikul Thailand 21 621 0.7× 633 1.2× 394 0.8× 349 0.9× 57 0.4× 58 1.3k
Nathaniel J. Rhodes United States 23 936 1.0× 577 1.1× 518 1.1× 506 1.3× 281 1.8× 96 1.6k
Lavern M. Vercaigne Canada 20 700 0.8× 625 1.2× 297 0.6× 481 1.3× 100 0.6× 40 1.7k
Paul M. Beringer United States 22 500 0.6× 362 0.7× 333 0.7× 286 0.8× 129 0.8× 64 1.4k
Milo Gatti Italy 24 901 1.0× 518 1.0× 359 0.7× 572 1.5× 150 0.9× 131 1.7k
Heino Staß Germany 21 614 0.7× 424 0.8× 171 0.4× 280 0.7× 114 0.7× 54 1.2k
H. Lode Germany 17 619 0.7× 545 1.0× 256 0.5× 407 1.1× 160 1.0× 47 1.4k

Countries citing papers authored by Norifumi Morikawa

Since Specialization
Citations

This map shows the geographic impact of Norifumi Morikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Norifumi Morikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Norifumi Morikawa more than expected).

Fields of papers citing papers by Norifumi Morikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Norifumi Morikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Norifumi Morikawa. The network helps show where Norifumi Morikawa may publish in the future.

Co-authorship network of co-authors of Norifumi Morikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Norifumi Morikawa. A scholar is included among the top collaborators of Norifumi Morikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Norifumi Morikawa. Norifumi Morikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Ide, Takeshi, Yoshio Takesue, Kazuro Ikawa, et al.. (2018). Population pharmacokinetics/pharmacodynamics of linezolid in sepsis patients with and without continuous renal replacement therapy. International Journal of Antimicrobial Agents. 51(5). 745–751. 31 indexed citations
5.
Sadahira, Takuya, Koichiro Wada, Kazuro Ikawa, et al.. (2017). Clinical pharmacokinetics of oral levofloxacin and sitafloxacin in epididymal tissue. Journal of Infection and Chemotherapy. 23(4). 214–217. 5 indexed citations
6.
Takeda, Yasuo, Kazuaki Matsumoto, Erika Watanabe, et al.. (2016). Pharmacokinetic/pharmacodynamic analysis of teicoplanin in patients with MRSA infections. Clinical Pharmacology Advances and Applications. 8. 15–15. 47 indexed citations
7.
Matsumoto, Kazuaki, Yuko Kuroda, Kazuro Ikawa, et al.. (2015). Pharmacokinetics and dosing estimation of meropenem in Japanese patients receiving continuous venovenous hemodialysis. Journal of Infection and Chemotherapy. 21(6). 476–478. 9 indexed citations
8.
Matsumoto, Kazuaki, Akari Shigemi, Erika Watanabe, et al.. (2014). Analysis of thrombocytopenic effects and population pharmacokinetics of linezolid: a dosage strategy according to the trough concentration target and renal function in adult patients. International Journal of Antimicrobial Agents. 44(3). 242–247. 117 indexed citations
9.
Kondo, Naru, Kazuro Ikawa, Yoshiaki Murakami, et al.. (2014). Clinical pharmacokinetics of meropenem in pancreatic juice and site-specific pharmacodynamic target attainment against Gram-negative bacteria: Dosing considerations. Pancreatology. 14(2). 95–99. 3 indexed citations
10.
Ikawa, Kazuro, Kogenta Nakamura, Yoshiaki Yamada, et al.. (2013). Prostatic penetration of meropenem in humans, and dosage considerations for prostatitis based on a site-specific pharmacokinetic/pharmacodynamic evaluation. International Journal of Antimicrobial Agents. 41(3). 267–271. 16 indexed citations
11.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, et al.. (2010). Pharmacokinetic–pharmacodynamic target attainment analysis of meropenem in Japanese adult patients. Journal of Infection and Chemotherapy. 16(1). 25–32. 22 indexed citations
12.
Ikawa, Kazuro, et al.. (2009). Population pharmacokinetic modeling and pharmacodynamic assessment of cefozopran in pediatric patients.. PubMed. 62(5). 435–44. 3 indexed citations
14.
Ikawa, Kazuro, Norifumi Morikawa, Kayo Ikeda, Hiroki Ohge, & Taijiro Sueda. (2008). Pharmacodynamic evaluation of biapenem in peritoneal fluid using population pharmacokinetic modelling and Monte Carlo simulation. International Journal of Antimicrobial Agents. 32(4). 339–343. 6 indexed citations
15.
Ikawa, Kazuro, Norifumi Morikawa, Seiichi Hayato, et al.. (2007). Pharmacokinetic and pharmacodynamic profiling of cefepime in plasma and peritoneal fluid of abdominal surgery patients. International Journal of Antimicrobial Agents. 30(3). 270–273. 25 indexed citations
16.
Ikawa, Kazuro, et al.. (2006). Development of Software Support Tool for Planning Administration of Biapenem, a Carbapenem Antibacterial Agent, based on Pharmacokinetic/Pharmacodynamic Approach and Monte Carlo Simulation. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 32(7). 622–628. 6 indexed citations
17.
Abe, Hiroko, et al.. (2002). Pharmaceutical Care Using POS (Problem Oriented System) for Psychotic Inpatients. First Report on Activities of the Kyushu POS Pharmaceutical Society.. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 28(3). 263–277.
18.
Morikawa, Norifumi, et al.. (2000). Pharmacokinetics of Cytosine Arabinoside, Methotrexate, Nimustine and Valproic Acid in Cerebrospinal Fluid during Cerebrospinal Fluid Perfusion Chemotherapy.. Biological and Pharmaceutical Bulletin. 23(6). 784–787. 4 indexed citations
19.
Morikawa, Norifumi, et al.. (1992). Development and Estimation of the Management System for Dispensing.. Japanese Journal of Hospital Pharmacy. 18(6). 584–593. 1 indexed citations
20.
Morikawa, Norifumi, Kazuo Mori, Isao Fujii, & Masaharu Takeyama. (1992). Pharmacokinetic Study in Acute Antiepileptic Intoxication Treated with Hemodialysis and Hemoperfusion.. Rinsho yakuri/Japanese Journal of Clinical Pharmacology and Therapeutics. 23(2). 469–474. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026